NCT06233162View on ClinicalTrials.gov

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 15, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Febuxostat-Test product

Febuxostat 80 mg tablets Manufactured by: Zydus Lifesciences Limited, India

DRUG

Febuxostat-Reference product

Febuxostat 80 mg tablets Manufactured by: Patheon France, France

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets | Biotech Hunter | Biotech Hunter